amifampridine has been researched along with Cerebellar Ataxia in 1 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
Cerebellar Ataxia: Incoordination of voluntary movements that occur as a manifestation of CEREBELLAR DISEASES. Characteristic features include a tendency for limb movements to overshoot or undershoot a target (dysmetria), a tremor that occurs during attempted movements (intention TREMOR), impaired force and rhythm of diadochokinesis (rapidly alternating movements), and GAIT ATAXIA. (From Adams et al., Principles of Neurology, 6th ed, p90)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sprenger, A | 1 |
| Rambold, H | 1 |
| Sander, T | 1 |
| Marti, S | 1 |
| Weber, K | 1 |
| Straumann, D | 1 |
| Helmchen, C | 1 |
1 trial available for amifampridine and Cerebellar Ataxia
| Article | Year |
|---|---|
Treatment of the gravity dependence of downbeat nystagmus with 3,4-diaminopyridine.
Topics: 4-Aminopyridine; Adult; Aged; Aged, 80 and over; Amifampridine; Cerebellar Ataxia; Electrooculograph | 2006 |